In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19.
Detection Principle
ImmunoAssay-Others
Target
S, nsp3, N and nsp12
Testing Method Category
In_silico
Testing Method
in silico prediction and ELISA
Testing Method - Additional Info
in silico prediction of epitopes and validation by testing with ELISA
Reported Performance
Sensitivity: 92.3% (S-RBD), 87.2% (N-Nterm), 93.8% (mix) ; Specificity: 100% (S-RBD, N-Nterm), 97.2% (mix)
Sample Size
80 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements